Highlights: Retatrutide targets GLP-1, GIP, and glucagon to reduce appetite, regulate fat storage, and manage blood sugar A trial showed a higher dose of Retatrutide produced 20% more weight loss over 48 weeks Common side effects include diarrhea, nausea, and vomiting , with at least one death reported Trusted Source Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial Go to source)
Appetite Regulation and Sustainable Weight Management One of the most challenging aspects of weight management involves persistent hunger and food cravings that undermine adherence to reduced-calorie diets
So, without insurance, it can cost just as much as Wegovy
The two biggest ongoing trials are TRIUMPH-1 (2,300 people with obesity) and TRIUMPH-2 (1,000 people with type 2 diabetes and obesity)
The mechanistic contrast with tirzepatide is covered in detail in retatrutide vs tirzepatide
Step 3 Precise Placement: Using a fine cannula, Dr